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Objective
To compare the perioperative, pathological and functional
outcomes in two contemporary, large series of patients in
diﬀerent institutions and who underwent open partial
nephrectomy (OPN) or robot-assisted PN (RAPN) for
suspected renal tumours.
Patients and Methods
This was a retrospective, multicentre, international,
matched-pair analysis comparing patients who underwent
RAPN or OPN for suspected renal cell carcinoma.
Data on patients who underwent OPN were extracted by an
Italian observational registry collecting data from 19 diﬀerent
centres.
Data on patients who received RAPN were extracted from a
multicentre, international database collecting cases treated in
four high-volume referral centres of robotic surgery.
The matching was in a 1:1 ratio for the surgical approach and
included 200 patients in each arm.
Results
The mean warm ischaemia time was shorter in the OPN
group than in the RAPN group, at a mean (SD) of 15.4 (5.9)
vs 19.2 (7.3) min (P < 0.001).
Conversely, the median (interquartile range) estimated blood
loss was 150 (100–300) mL in the OPN group and 100
(50–150) mL in the RAPN group (P < 0.001).
There were no diﬀerences in operating time (P = 0.18) and
the intraoperative complication rate (P = 0.31) between the
approaches.
Postoperative complications were recorded in 43 (21.5%) patients
who underwent OPN and in 28 (14%) who received RAPN (P =
0.02).Moreover, major complications (grade 3–4) were reported
in nine (4.5%) patients after OPN and in nine (4.5%) after RAPN.
Positive margins were detected in nine (5.5%) patients after
OPN and in nine (5.7%) after RAPN (P = 0.98). The mean (SD)
3-month estimated glomerular ﬁltration rate declined by 16.6
(18.1) mL/min from the preoperative value in the OPN group
and by 16.4 (22.9) mL/min in the RAPN group (P = 0.28).
Conclusion
RAPN can achieve equivalent perioperative, early oncological
and functional outcomes as OPN. Moreover, RAPN is a less
invasive approach, oﬀering a lower risk of bleeding and
postoperative complications than OPN.
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Introduction
Partial nephrectomy (PN) is currently the ‘gold-standard’
treatment for localised renal tumours of <7 cm [1]. PN is
associated with lower renal function impairment [2], better
overall survival and equivalent oncological survival compared
with radical nephrectomy [3–5]. Therefore, the surgical
feasibility according to the surgeon’s expertise and preferences
remains the main factor inﬂuencing the ﬁnal decision.
In recent decades many authors have proposed laparoscopic
PN (LPN) and robot-assisted PN (RAPN) as less invasive
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alternatives to open PN (OPN). Although LPN was able to
oﬀer better cosmetic results, less postoperative pain, shorter
hospitalisation and postoperative recovery than OPN, the
steep learning curve limited its diﬀusion to a few high-volume
reference centres, and for small and less complex tumours [6].
RAPN has been developed and proposed as the natural
evolution and simpliﬁcation of LPN. Indeed, the advantages
oﬀered by the Da Vinci platform (Intuitive Surgical, CA, USA;
three-dimensional vision and patented EndoWrist™
technology) can help surgeons to reduce the learning curve
and to increase the feasibility of a laparoscopic approach also
for the treatment of more complex and/or large renal
tumours.
Recently, two meta-analyses of the results of the available
studies comparing LPN and RAPN reported conﬂicting
results.While Aboumarzouk et al. [7] reported a signiﬁcant
decrease of warm ischaemia time (WIT) in a RARP series,
Froghi et al. [8] did not report signiﬁcant diﬀerences in
perioperative variables between the approaches. However,
large comparative studies not included in the previous
meta-analyses showed a signiﬁcant advantage in favour of
RAPN for WIT, estimated blood loss (EBL), hospital stay and
risk of major complications [9,10].
Some authors recently highlighted that LPN should not be
considered as a suitable referent for RAPN [11]. Indeed,
previous data convincingly support the concept that RAPN is
a very attractive adaptation to duplicate the performance of
OPN, even in more complex cases. However, only a few
retrospective, single-centre studies have compared RAPN with
OPN. These studies showed a longer WIT in the RAPN cohort
but overlapping results for positive surgical margins (PSMs),
perioperative complications and renal functional outcomes
[12,13].
In the present study, we used a matched-pair analysis between
contemporary large series of patients in diﬀerent institutions
who underwent OPN or RAPN for suspected renal tumours.
The aim of the study was to compare the perioperative,
pathological and functional outcomes in the two cohorts.
Patients and Methods
Data of patients who underwent OPN (368) were extracted
from the preliminary analysis of the REgistry of COnservative
Renal surgery database (RECORd Project) promoted by the
‘Leading Urological No proﬁt foundation Advanced research’
(LUNA) of the Italian Society of Urology (SIU) to collect the
clinical records of patients who had PN for cT1 renal tumours
between January 2009 and January 2011 at 19 urological
centres in Italy. Data from patients who had RAPN were
extracted from a multicentre, international database including
415 patients in four centres (Aalst, Belgium; Milan San
Raﬀaele, Italy; Washington University School of Medicine, St
Louis, MO, USA; and Swedish Urology Group, Seattle,WA,
USA), from September 2008 to September 2010.
Clinical staging included an abdominal CT and chest X-rays.
MRI was used in a few patients as an alternative to CT. Bone
scans and brain CT were obtained only when indicated by the
signs and symptoms.
OPN procedures were performed by several expert surgeons
using mainly a ﬂank retroperitoneal approach. According to
the surgeon’s preference, the tumour was excised with
(standard PN) or without (simple enucleation) an adequate
rim of healthy renal parenchyma around the pseudocapsule.
Tumour excision was done by clamping the renal artery
(warm ischaemia) or with no clamping, using manual
compression of the surrounding renal parenchyma. Opened
calyces and bleeding sites were sutured and the parenchymal
defect was closed with horizontal interrupted sutures with
or without the application of haemostatic agents (FloSeal®,
Baxter Healthcare; Tachosil®, Nycomed; Tabotamp®,
Ethicon).
RAPN procedures were performed in high-volume centres by
four surgeons (A.M., S.B., J.P., G.G.) with extensive robotic
experience, including robotic radical prostatectomy, robotic
radical nephrectomy and for some surgeons, robotic radical
cystectomy. A transperitoneal approach was used in most
cases. In all cases a standard PN was performed. The renal
artery was clamped until the end of the renal parenchyma
reconstruction in most cases. The renal vein was clamped only
for more complex tumours. If the collecting system had been
entered, or if large vessels remained patent, a repair with
absorbable suture materials was made before proceeding with
renorrhaphy. The parenchymal defect was repaired using the
sliding-clip technique. If necessary, haemostatic agents were
used.
The following preoperative variables were extracted from the
databases: age, gender, clinical tumour size, polar location,
tumour exophytic rate (>50% exophytic, <50% exophytic,
entirely endophytic), clinical TNM stage, preoperative blood
haemoglobin and serum creatinine, and estimated GFR
(eGFR) calculated with the Modiﬁcation of Diet in Renal
Disease equation [14].
The following intraoperative variables were evaluated: the use
of pedicle clamping; WIT; operating time (calculated as the
time from skin incision to skin closure); EBL; and
intraoperative complications.
For every patient, the following pathological variables were
recorded: tumour size, extension of the primary tumour
according to the 2009 version of the TNM classiﬁcation [15],
histological subtypes according to the WHO classiﬁcation [16],
the nuclear grade according to the Fuhrman classiﬁcation [17],
and the surgical margin status. A PSM was deﬁned as cancer
cells at the level of the inked parenchymal excision surface.
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There was no central pathological slide review and the
pathological features were assigned by the uro-pathologists of
each participating centre.
The complications at 3 months after surgery were classiﬁed
according to the Dindo modiﬁcation of the Clavien system
[18]. Postoperative complications were distinguished as minor
(grade 1–2) and major (grade 3–4). The eGFR at 3 months
after surgery was calculated to evaluate the potential eﬀect of
surgery on overall renal function.
The propensity score for matching was assessed using R
Project, a method that controls for imbalances in confounding
factors among discrete study cohorts [19,20]. The propensity
score was calculated for each patient using multivariable
logistic regression based upon the following covariates: age,
clinical tumour size, longitudinal location (upper or inferior
poles vs middle pole) and tumour exophytic rate (<50%
exophytic vs others). The matching was in a 1:1 ratio for the
surgical approach (OPN vs RAPN) and included 200 patients
in each arm.
Continuous parametric variables were reported as the mean ±
standard deviation (SD), while nonparametric variables were
reported as the median and interquartile range (IQR). The
Mann–Whitney U-test and unpaired Student’s t-test were used
to compare continuous variables, as appropriate. Categorical
variables are reported as frequencies and proportions.
Pearson’s chi-square test was used to compare categorical
variables. For all statistical analyses, a two-sided P < 0.05 was
considered to indicate statistical signiﬁcance.
Results
The preoperative characteristics of the patients are
summarised in Table 1. For the laboratory variables, the
haemoglobin (P = 0.94), serum creatinine (P = 0.99), and
eGFR (P = 0.72) levels overlapped in the two groups of
patients.
The renal artery was clamped in only 138 (69%) patients who
underwent OPN. Conversely, 180 (90%) RAPNs were
performed with warm ischaemia (P < 0.001). The median
(IQR) WIT was 15 (11–19) and 18 (14–23) min for OPN and
RAPN, respectively (P < 0.001). In detail, a WIT of >20 min
was recorded in 21 (10.5%) patients after OPN and in 61
(30.5%) after RAPN (P < 0.001). Only two (1%) patients in the
OPN group and 10 (5%) in the RAPN group had a WIT of
>30 min (P = 0.06). The median (IQR) EBL was 150 (100–300)
mL in the OPN group and 100 (50–150) mL in the RAPN
group (P < 0.001). There were no diﬀerences in operating time
(P = 0.19) and intraoperative complication rate (P = 0.31)
between the approaches. Speciﬁcally, intraoperative
complications included two venous injuries and one splenic
injury in the OPN group, and one renal vein injury in the
RAPN group. All previous complications were repaired during
surgery without conversion to open surgery for the robotic
procedures. Table 2 summarises the intraoperative data
stratiﬁed according to the diﬀerent surgical approaches. The
baseline and postoperative mean (SD) haemoglobin levels (at
3 days after surgery) were 2.7 (1.5) g/dL in the OPN group
and 2 (1.5) g/dL in the RAPN group (P < 0.001). Moreover,
20 (10.3%) patients in the OPN group and 21 (10.5%) in the
RAPN group received a blood transfusion during the
perioperative period (P = 0.78). The median (IQR) length of
stay was 7 (6–8) days for OPN and 6 (5–6) days for RAPN
(P = 0.014). Postoperative complications were recorded in 43
(21.5%) patients who underwent OPN and in 28 (14%) who
had RAPN (P = 0.02). In detail, major complications (grade
3–4) were reported in nine (4.5%) patients each after OPN
and RAPN. Minor complications (grade 1–2) were recorded in
Table 1 Preoperative characteristics of patients and tumours stratified according to surgical
approach.
Preoperative variable RPN OPN P
N = 200 N = 200
Mean (SD) age, years 62.4 (10.6) 62.4 (11.8) 0.94
Gender, n (%) 0.12
male 121 (60.5) 131 (65.5)
female 79 (39.5) 69 (34.5)
Median (IQR) clinical tumour diameter, cm 2.8 (1.9–3.5) 3.0 (2.0–3.5) 0.13
Longitudinal tumour location, n (%) 0.31
polar 124 (62) 114 (57)
non-polar 76 (38) 86 (43)
Percentage of tumour deepening into the kidney, n (%) 0.45
≥50% exophytic 142 (71) 135 (67.5)
<50% exophytic/completely intrarenal 58 (29) 65 (32.5)
Clinical T stage, n (%) 0.66
cT1a 171 (85.5) 174 (87)
cT1b 29 (14.5) 26 (13)
Median (IQR):
Preoperative haemoglobin, g/dL 14 (13–15) 14 (13–15) 0.94
Preoperative serum creatinine, mg/dL 1.0 (0.8–1.1) 0.9 (0.8–1.1) 0.99
Preoperative eGFR, mL/min 81.0 (69.0–91.7) 83.4 (70.3–94.1) 0.72
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34 (17%) patients after OPN and in 19 (9.5%) after RAPN
(P = 0.03). Table 3 details the perioperative outcomes stratiﬁed
according to the two approaches.
The deﬁnitive histopathological examination showed 37
(17.5%) benign tumours (angiomyolipomas or oncocytomas)
in the OPN group and 42 (21%) in the RAPN group,
respectively (P = 0.63). there were no signiﬁcant diﬀerences in
pathological extension of the primary tumour (P = 0.54) and
Fuhrman nuclear grade (P = 0.72). PSMs were detected in
nine (5.5%) patients after OPN and in nine (5.7%) after RAPN
(P = 0.98). Table 4 summarises the pathological features
according to the two approaches.
At 3 months after surgery, the mean (SD) eGFR declined by
16.6 (18.1) mL/min from the preoperative value in the OPN
group and by 16.4 (22.9) mL/min in the RAPN group
(P = 0.28).
Discussion
The present matched-pair analysis showed that RAPN is a
valid alternative to OPN in patients with suspected cT1 renal
tumours. Although OPN oﬀered the advantages of a higher
percentage of operations without renal artery clamping and a
shorter WIT than RAPN, the robot-assisted approach was
associated with a statistically signiﬁcantly lower risk of blood
loss (although this was probably not clinically relevant), of
postoperative complications, and with a shorter hospital stay.
The rate of PSMs, and early functional outcomes evaluated
using the eGFR, at 3 months after surgery showed overlapping
results between the techniques.
Most of the comparative studies reported previously tested
RAPN vs LPN. Two recent meta-analyses showed only
minimal advantages in favour of RAPN in terms of a shorter
WIT [7,8]. However, both meta-analyses provided a
combination of data coming from small, observational studies
in which the LPN group was represented by historical series
and the RAPN group was strongly inﬂuenced by the surgeons’
learning curve [21]. Moreover, the two larger comparative
studies were not included in both meta-analyses for
methodological reasons. Both studies showed signiﬁcant
advantages in favour of RAPN for WIT, EBL, hospital stay
[9,10] and the risk of major complications [10].
Similarly, only a few observational studies comparing RAPN
and OPN have been reported. In 2011, Lee et al. [12]
retrospectively compared 69 RAPN and 234 OPN procedures
in patients comparable in age, gender, clinical tumour size and
preoperative eGFR. Although the mean WIT was longer in the
RAPN group, no signiﬁcant diﬀerences in postoperative eGFR
and change in the eGFR were detected. Moreover, the hospital
stay, use of analgesics and overall postoperative complication
rates were signiﬁcantly in favour of the RAPN group [12]. The
Table 2 Intraoperative outcomes stratified according to the different surgical approach.
Intraoperative variable RAPN OPN P
N = 200 N = 200
Artery clamping, n (%) 180 (90) 138 (69) <0.001
Median (IQR; range) WIT, min 18 (14–23; 5–51) 15 (11–19; 4–34) <0.001
N (%):
WIT >20 min 61 (30.5) 21 (10.5) <0.001
WIT >25 min 31 (15.5) 8 (4) 0.002
WIT >30 min 10 (5) 2 (1) 0.06
Median (IQR) EBL, mL 100 (50–150) 150 (100–300) <0.001
Median (IQR) operating time, min 120 (90-157) 127 (96–166) 0.19
Intraoperative complications, n (%) 1 (0.5) 3 (1.5) 0.31
Table 3 Perioperative outcomes stratified according to the different
surgical approach.
Variables RAPN OPN P
N = 200 N = 200
Median (IQR) length of stay (including
day of surgery), days
6 (5–6) 7 (6–8) 0.014
n/N (%):
Postoperative overall complications 28/200 (14) 43/200 (21.5) 0.027
Clavien severity grade:
1–2 19 (9.5) 34 (17) 0.030
3 8 (4) 7 (3.5) 0.34
4 1 (0.5) 2 (1) –
Transfusion rate 21/200 (10.5) 20/200 (10) 0.78
Table 4 Pathological features stratified according to the different surgical
approach.
Variables RAPN OPN P
N = 200 N = 200
n/N (%):
Benign tumours 42 (21) 37 (17.5) 0.63
TNM 2009: 0.54
pT1a 132/158 (83.5) 126/163 (77.3)
pT1b 18/158 (11.4) 24/163 (14.7)
pT2 – –
pT3a 8/158 (5.1) 13/163 (8.0)
Fuhrman grade: 0.72
1 25/158 (15.8) 33/163 (20.2)
2 97/158 (61.4) 97/163 (59.5)
3–4 36/158 (22.8) 33/163 (20.2)
PSM 9/158 (5.7) 9/163 (5.5) 0.98
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previous favourable outcomes were conﬁrmed also by Simhan
et al. [13] in 2012, comparing the outcomes of 91 RAPN and
190 OPN for moderately and highly complex renal lesions,
according to R.E.N.A.L. nephrometry [consists of (R)adius
(tumour size as maximal diameter), (E)xophytic/endophytic
properties of the tumour, (N)earness of tumour deepest
portion to the collecting system or sinus, (A)nterior
(a)/posterior (p) descriptor and the (L)ocation relative to the
polar line]. Indeed, in this non-matched-pair analysis, the
authors showed that RAPN oﬀered comparable perioperative
and functional outcomes with a shorter hospital stay than
OPN [13]. In the same year, Lucas et al. [22], in a small,
retrospective, comparative study analysing 27 RAPN and 54
OPN, showed a shorter WIT in the OPN group but a greater
blood loss and hospital stay than in the RAPN group.
Perioperative complications and renal functional preservation
were similar for each treatment.
Similar to the present study, in a small matched-pair analysis
including only 27 RAPN and 54 OPN, Mellon et al. [23]
reported overlapping PSM rates between RAPN and OPN.
Moreover, the authors showed that the mean distance to the
proximal margin edge for RAPN specimens was equivalent to
those in OPN [23].
Considering the clinical characteristics of patients included
in the present study, our conclusions should be further
conﬁrmed in other studies enrolling a higher percentage of
cT1b tumours. In 2013, Sprenkle et al. [24] compared
minimally invasive (LPN and RAPN) PN and OPN for the
treatment of cT1b renal tumours. Although that study
concluded that minimally invasive PN procedures oﬀer
acceptable and comparable results for operative, functional
and convalescence measures, the conclusions were based on
only 16 robotic procedures evaluated retrospectively.
The present study has some limitations. Although the
matched-pair analysis allowed control for imbalanced factors
among the two study cohorts, this was not a randomised
controlled trial. Moreover, the two cohorts were not adjusted
for some potential confounding factors, e.g. patient
comorbidity. However, the two cohorts were matched for
age and were not signiﬁcantly diﬀerent in preoperative
haemoglobin and serum creatinine levels. The two groups
were also not adjusted for tumour characteristics included in
the most used nephrometry systems, e.g. renal rim location
(medial or lateral), renal sinus and collecting system
involvement, and face location (anterior or posterior). Another
limitation is the lack of some anatomical information in the
RECORD database generated in 2008, before the publication
of the most common nephrometry systems (R.E.N.A.L.
nephrometry and Preoperative Aspects and Dimensions
Used for an Anatomical [PADUA] classiﬁcation) [25,26].
Considering the observational design of both the RECORD
project and PN robotic database, as well as the number of
centres and surgeons involved, the surgical approaches and
techniques resulted in heterogeneity. However, this potential
limitation reﬂects the real-life situation in which patients are
usually treated. For these reasons the RECORd 2 project
was started in January 2013, including both PADUA and
R.E.N.A.L. nephrometry scores, as well as the American
Society of Anesthesiologists physical status classiﬁcation
system, Charlson score and age-adjusted Charlson score.
A further limitation is represented by the potential eﬀect of
the learning curve on the outcomes.Whilst most patients
underwent OPN conducted by expert surgeons, some data
extracted from the RAPN databases were the initial cases
operated by the four participating surgeons. Therefore,
according to the Idea, Development, Exploration, Assessment,
Long-term follow-up (IDEAL) criteria, this study cannot
be considered formally as an ‘Assessment study’ comparing
RAPN with the surgical ‘gold standard’ (OPN), but it should
be considered in the context of the evaluation step of the
RAPN [27].
In conclusion, the present study showed that RAPN can attain
equivalent perioperative and functional outcomes as OPN in
patients with suspected cT1 renal tumours. Moreover, RAPN
is a less invasive approach, oﬀering a lower risk of bleeding
and postoperative complications than OPN. However, the
latter procedure is associated with a shorter WIT and a higher
percentage of unclamped procedures. The overall renal
function evaluated at 3 months after surgery seems to be
equivalent between the approaches. The results in the RAPN
group could be negatively inﬂuenced by the learning curve of
the surgeons. Indeed, some initial robotic cases could possibly
have been included in the matching analysis of the 200 cases
and then compared with the 200 OPN cases. Therefore,
further studies excluding patients operated during the learning
curve should be planned to assess deﬁnitively the performance
of RAPN vs OPN. Moreover, the present results should not be
applied to small-volume robotic centres and to inexperienced
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